Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Signaling - Call For Papers

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 4 August 2006:
Vol. 313. no. 5787, pp. 670 - 673
DOI: 10.1126/science.1129594
Prev | Table of Contents | Next

Reports

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

Yoshikatsu Kaneko,* Falk Nimmerjahn,* Jeffrey V. Ravetch{dagger}

Immunoglobulin G (IgG) mediates pro- and anti-inflammatory activities through the engagement of its Fc fragment (Fc) with distinct Fcg receptors (FcgRs). One class of Fc-FcgR interactions generates pro-inflammatory effects of immune complexes and cytotoxic antibodies. In contrast, therapeutic intravenous gamma globulin and its Fc fragments are anti-inflammatory. We show here that these distinct properties of the IgG Fc result from differential sialylation of the Fc core polysaccharide. IgG acquires anti-inflammatory properties upon Fc sialylation, which is reduced upon the induction of an antigen-specific immune response. This differential sialylation may provide a switch from innate anti-inflammatory activity in the steady state to generating adaptive pro-inflammatory effects upon antigenic challenge.

Laboratory of Molecular Genetics and Immunology, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.

* These authors contributed equally to this work.

{dagger} To whom correspondence should be addressed. E-mail: ravetch{at}rockefeller.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions.
E. A. Hod, C. M. Cadwell, J. S. Liepkalns, J. C. Zimring, S. A. Sokol, D. A. Schirmer, J. Jhang, and S. L. Spitalnik (2008)
Blood 112, 891-894
   Abstract »    Full Text »    PDF »
The Antiinflammatory IgG.
S. V. Kaveri, S. Lacroix-Desmazes, and J. Bayry (2008)
N. Engl. J. Med. 359, 307-309
   Full Text »    PDF »
Immunosuppression of EAMG by IVIG Is Mediated by a Disease-specific Anti-immunoglobulin Fraction.
S. FUCHS, T. FEFERMAN, R. MEIDLER, R. MARGALIT, C. SICSIC, T. BRENNER, O. LAUB, and M. C. SOUROUJON (2008)
Ann. N.Y. Acad. Sci. 1132, 244-248
   Abstract »    Full Text »    PDF »
Sweet and sour: the impact of sugars on disease.
A. Alavi and J. S. Axford (2008)
Rheumatology 47, 760-770
   Abstract »    Full Text »    PDF »
Response of Dystrophic Calcification to Intravenous Immunoglobulin.
S. Schanz, A. Ulmer, and G. Fierlbeck (2008)
Arch Dermatol 144, 585-587
   Full Text »    PDF »
Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc.
R. M. Anthony, F. Nimmerjahn, D. J. Ashline, V. N. Reinhold, J. C. Paulson, and J. V. Ravetch (2008)
Science 320, 373-376
   Abstract »    Full Text »    PDF »
From the Cover: IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
M. Collin, O. Shannon, and L. Bjorck (2008)
PNAS 105, 4265-4270
   Abstract »    Full Text »    PDF »
Making autoantibodies safe.
C. N. Scanlan, D. R. Burton, and R. A. Dwek (2008)
PNAS 105, 4081-4082
   Full Text »    PDF »
Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis.
A. S. Mehta, R. E. Long, M. A. Comunale, M. Wang, L. Rodemich, J. Krakover, R. Philip, J. A. Marrero, R. A. Dwek, and T. M. Block (2008)
J. Virol. 82, 1259-1270
   Abstract »    Full Text »    PDF »
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.
A. Ephrem, S. Chamat, C. Miquel, S. Fisson, L. Mouthon, G. Caligiuri, S. Delignat, S. Elluru, J. Bayry, S. Lacroix-Desmazes, et al. (2008)
Blood 111, 715-722
   Abstract »    Full Text »    PDF »
Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion.
J. Chang, P. A. Shi, E. Y. Chiang, and P. S. Frenette (2008)
Blood 111, 915-923
   Abstract »    Full Text »    PDF »
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool.
O. Hershkovitz, M. Jarahian, A. Zilka, A. Bar-Ilan, G. Landau, S. Jivov, Y. Tekoah, R. Glicklis, J. T. Gallagher, S. C. Hoffmann, et al. (2008)
Glycobiology 18, 28-41
   Abstract »    Full Text »    PDF »
Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG.
R. Saldova, L. Royle, C. M Radcliffe, U. M Abd Hamid, R. Evans, J. N Arnold, R. E Banks, R. Hutson, D. J Harvey, R. Antrobus, et al. (2007)
Glycobiology 17, 1344-1356
   Abstract »    Full Text »    PDF »
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange.
M. van der Neut Kolfschoten, J. Schuurman, M. Losen, W. K. Bleeker, P. Martinez-Martinez, E. Vermeulen, T. H. den Bleker, L. Wiegman, T. Vink, L. A. Aarden, et al. (2007)
Science 317, 1554-1557
   Abstract »    Full Text »    PDF »
Intravenous Immunoglobulin and Autoimmune Disease.
T. EL-SHANAWANY and S. JOLLES (2007)
Ann. N.Y. Acad. Sci. 1110, 507-515
   Abstract »    Full Text »    PDF »
Depletion of B Cells in Murine Lupus: Efficacy and Resistance.
A. Ahuja, J. Shupe, R. Dunn, M. Kashgarian, M. R. Kehry, and M. J. Shlomchik (2007)
J. Immunol. 179, 3351-3361
   Abstract »    Full Text »    PDF »
A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects.
S. E. Strome, E. A. Sausville, and D. Mann (2007)
Oncologist 12, 1084-1095
   Abstract »    Full Text »    PDF »
Immune Complex Pathophysiology.
U. E. NYDEGGER (2007)
Ann. N.Y. Acad. Sci. 1109, 66-83
   Abstract »    Full Text »    PDF »
Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures.
M. Sack, A. Paetz, R. Kunert, M. Bomble, F. Hesse, G. Stiegler, R. Fischer, H. Katinger, E. Stoeger, and T. Rademacher (2007)
FASEB J 21, 1655-1664
   Abstract »    Full Text »    PDF »
The Neutralization Properties of a HIV-Specific Antibody Are Markedly Altered by Glycosylation Events Outside the Antigen-Binding Domain.
L. R. Miranda, M. Duval, H. Doherty, M. S. Seaman, M. R. Posner, and L. A. Cavacini (2007)
J. Immunol. 178, 7132-7138
   Abstract »    Full Text »    PDF »
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.
F. Nimmerjahn, R. M. Anthony, and J. V. Ravetch (2007)
PNAS 104, 8433-8437
   Abstract »    Full Text »    PDF »
Sialylated therapeutic IgG: a sweet remedy for inflammatory diseases?.
J. D. Dimitrov, J. Bayry, S. Siberil, and S. V. Kaveri (2007)
Nephrol. Dial. Transplant. 22, 1301-1304
   Full Text »    PDF »
Sialic Acid on Herpes Simplex Virus Type 1 Envelope Glycoproteins Is Required for Efficient Infection of Cells.
J. R. Teuton and C. R. Brandt (2007)
J. Virol. 81, 3731-3739
   Abstract »    Full Text »    PDF »
Lectins: Carbohydrate-specific Reagents and Biological Recognition Molecules.
N. Sharon (2007)
J. Biol. Chem. 282, 2753-2764
   Full Text »    PDF »
The antiinflammatory activity of IgG: the intravenous IgG paradox.
F. Nimmerjahn and J. V. Ravetch (2007)
J. Exp. Med. 204, 11-15
   Abstract »    Full Text »    PDF »
T-Cell Costimulation.
M. P. Wise, A. Gallimore, A. Godkin, C. A.L.S. Colaco, A. Sharpe, and A. Abbas (2006)
N. Engl. J. Med. 355, 2594-2595
   Full Text »    PDF »
N-Linked Glycosylation of Folded Proteins by the Bacterial Oligosaccharyltransferase..
M. Kowarik, S. Numao, M. F. Feldman, B. L. Schulz, N. Callewaert, E. Kiermaier, I. Catrein, and M. Aebi (2006)
Science 314, 1148-1150
   Abstract »    Full Text »    PDF »


ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)